Examining RSL3-induced activation of Keap1-Nrf2-ARE pathway
Examining RSL3-induced activation of Keap1-Nrf2-ARE pathway
arigo is proud to announce that our Keap1-Nrf2-ARE antibody panel (ARG30345) was referenced by Kuo et al. for examining Nrf2/HO-1 activation induced by RSL3. This antibody panel comprises Nrf2 antibody as well as Nrf2 regulator Keap1 and antioxidant enzymes NQO1 and HO-1 antibodies. It is the best solution to facilitate the research of Keap1-Nrf2-ARE pathway.
|
Keap1-Nrf2-ARE Antibody Panel (ARG30345) ● Includes IP-available Nrf2 antibody Data from Kuo et al., (2024) Int J Med Sci. 21(7):1257-1264. |
|
Cellular effects of Nrf2
Nrf2 is a master regulator of antioxidant responses. It mediates cellular resistance to oxidants by regulating gene expression for eliminating ROS, promoting autophagy, inhibiting ferroptosis, and delaying senescence. Nrf2 is emerging as an attractive therapeutic approach in diseases associated with oxidative stress. arigo offers multiple antibody panels for investigating the roles of Nrf2 in various cellular responses.
Ferroptosis/Oxytosis Antibody ● GPX4 ● xCT |
Senescence Marker Antibody ● p16 ● Rb pSer807 |
Autophagy Antibody Panel (ARG30321) ● LC3B ● SQSTM1 |